FINANCIALS

RSLS Reshape Lifesciences Inc 1427570

Income Statement
Revenue	rsls-20240930x10q	2,292,000
Net Income	rsls-20240930x10q	-1,581,000
Profit Margin		-68.98%

Balance Sheet
Current Assets	5,338,000
Assets	5,615,000
Current Liabilities	4,025,000
Liabilities	4,128,000
Equity	1,487,000
Shares Out	29,387,000

Cash Flow Statement
Operating Cash Flow	-3,740,000

Market Analysis
Market Cap	4,760,019
Price	4.52
BVPS	0.05
PB	89.53
EPS	-1.29
PS	0.52

Dividends

Earnings

Find a discrepancy? The most accurate way to find company fundamental data is to view RSLS documents filed with the SEC.

RSLS Filings Clear

View A List of Tickers